Ads
related to: cprx after hourswktrader.com has been visited by 10K+ users in the past month
Search results
Catalyst (CPRX) Q2 Earnings & Sales Top, 2023 Outlook Raised
Zacks via Yahoo Finance· 8 months agoShares of Catalyst Pharmaceuticals, Inc. CPRX climbed 6.4% on Thursday after the company reported...
Catalyst (CPRX) Q4 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 2 months agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted diluted earnings of 53 cents per share for the...
Catalyst Pharmaceuticals (CPRX) Q2 Earnings Top, Revenues Up
Zacks via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals, Inc. CPRX reported earnings of 20 cents per share in the second quarter of...
Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 574%
Simply Wall St. via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) shareholders might be concerned after seeing the share...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up by...
Will Weakness in Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Prove Temporary Given Strong...
Simply Wall St. via Yahoo Finance· 9 months agoWith its stock down 17% over the past three months, it is easy to disregard Catalyst Pharmaceuticals...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) high institutional ownership speaks for itself as...
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Institutions' substantial holdings in Catalyst Pharmaceuticals implies that they have...
Are Investors Undervaluing Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) By 50%?
Simply Wall St. via Yahoo Finance· 1 year agoHow far off is Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) from its intrinsic value? Using the most...
The 6.3% return this week takes Catalyst Pharmaceuticals' (NASDAQ:CPRX) shareholders five-year gains...
Simply Wall St. via Yahoo Finance· 2 years agoWe think all investors should try to buy and hold high quality multi-year winners. And highest...
Here's Why Catalyst Pharmaceuticals (NASDAQ:CPRX) Has Caught The Eye Of Investors
Simply Wall St. via Yahoo Finance· 1 year agoIt's common for many investors, especially those who are inexperienced, to buy shares in companies...
